Biotech

All Articles

Amgen records initial period 3 win for $400M eczema medicine

.Amgen has actually shared (PDF) the initial period 3 data on its $400 thousand dermatitis drug, lin...

Biogen, UCB document period 3 lupus succeed after neglecting earlier test

.Biogen as well as UCB's bank on improving right into phase 3 on the back of an unsuccessful researc...

Aptadir wishes brand-new RNA preventions may reverse tricky cancers

.Italian biotech Aptadir Rehabs has actually launched along with the guarantee that its pipeline of ...

Wave surfs DMD excellence to regulators' doors, delivering stock up

.Surge Life Sciences has satisfied its own objective in a Duchenne muscle dystrophy (DMD) research s...

Sanofi plucks new CSO from in-stealth biotech

.After a handful of years in biotech, Mike Quigley, Ph.D., is coming back to the pharma fold, using ...

Achilles drops tissue therapy program, prepares for unemployments after overlooking 'commercial feasibility' goals

.Achilles Therapeutics has actually shreded its strategy. The English biotech is quiting working on ...

Aligos heralds period 2 MASH gain, reducing liver excess fat up to 46%

.Aligos Rehabs is actually trumpeting a midstage succeed in metabolic-dysfunction linked steatohepat...

Basilea scores $268M BARDA backing for antifungals, prescription antibiotics

.Basilea Pharmaceutica's job cultivating brand new antifungals has actually received a substantial i...

Capricor offers Europe liberties to late-stage DMD treatment for $35M

.Having actually gathered up the USA liberties to Capricor Therapies' late-stage Duchenne muscle dys...

FDA scraps adcomm for Applied's unusual ailment medication

.After pushing back the decision meeting for Applied Rehabs' metabolic problem drug govorestat, the ...